ADHD Medication Linked to Mortality Rates in ADHD Patients

JAMA Network

About The Study: In this observational, target trial emulation analysis that included 148,000 individuals diagnosed with attention-deficit/hyperactivity disorder (ADHD) in Sweden, initial dispensation of ADHD medication was significantly associated with lower all-cause and unnatural-cause mortality, whereas the association with natural-cause mortality was not significant.

Authors: Zheng Chang, Ph.D., and Lin Li, Ph.D., of the Karolinska Institutet in Stockholm, are the corresponding authors.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2024.0851)

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.